Schmidt David sold (to issuer) $772K of ASTH
Schmidt David sold (to issuer) 20,000 shares of Astrana Health, Inc. (ASTH) at $38.59 ($0.77M total) on 2026-08-14.
How this was made
The 30-second read
Why it matters
The newest disclosed fact is the director’s sale of 20,000 shares at $38.59, totaling $771,800, with post-transaction holdings of 36,019 shares.
Market read
Traders may note insider selling activity, but there is no accompanying fundamental catalyst in the filing text.
What to watch
No 10b5-1 plan is cited, but the article also provides no reason for the sale, so interpreting it as a strong signal is risky.
Background
The article is an SEC Form 4 insider transaction disclosure for Astrana Health, Inc.
Ticker impact
Astrana Health director David Schmidt sold 20,000 shares to the issuer at $38.59 on 2026-08-14, per Form 4.
Likely limited near-term impact; any effect should be small and sentiment-driven unless follow-on filings show broader selling.
The filing is a Form 4 insider transaction with a defined price and size, but it does not include new company fundamentals, guidance, or regulatory/legal developments.
Market effects
No sector-level signal; this is company-specific insider activity.
None indicated.
None indicated.
Counterpoint
Because the code indicates sale to the issuer, it may reflect routine buyback participation rather than a bearish view on the stock.
Key entities
- issuerAstrana Health, Inc.
Subject of the Form 4 insider transaction disclosure.
- insiderSchmidt David
Director who sold shares to the issuer.
